Trump’s remarks stoke fears about FDA leadership

Former President Donald Trump’s embrace of Robert F. Kennedy Jr. has sparked concerns in the biopharma industry over the politicization of public health agencies, especially FDA, should he be re-elected.

Democrats and some Republicans worry that Trump will follow through on his commitments to empower RFK Jr., an anti-vaccine advocate and promoter of health misinformation, while other Republicans believe Trump’s support for Kennedy will not outlive the elections. ...